Michael Wiederhorn
Stock Analyst at Oppenheimer
(3.64)
# 834
Out of 4,996 analysts
134
Total ratings
55.73%
Success rate
4.43%
Average return
Main Sectors:
Stocks Rated by Michael Wiederhorn
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CHE Chemed | Maintains: Outperform | $650 → $580 | $462.23 | +25.48% | 13 | Jul 31, 2025 | |
| UNH UnitedHealth Group | Maintains: Outperform | $400 → $325 | $344.08 | -5.55% | 17 | Jul 30, 2025 | |
| CNC Centene | Maintains: Outperform | $51 → $43 | $34.86 | +23.35% | 19 | Jul 28, 2025 | |
| HUM Humana | Maintains: Outperform | $300 → $310 | $254.95 | +21.59% | 13 | May 1, 2025 | |
| CI The Cigna Group | Maintains: Outperform | $400 → $375 | $286.17 | +31.04% | 11 | Jan 31, 2025 | |
| TDOC Teladoc Health | Maintains: Outperform | $14 → $12 | $8.16 | +47.06% | 11 | Jan 24, 2025 | |
| PNTG The Pennant Group | Maintains: Outperform | $34 → $37 | $25.40 | +45.67% | 6 | Nov 8, 2024 | |
| HCA HCA Healthcare | Maintains: Outperform | $390 → $400 | $419.08 | -4.55% | 11 | Oct 28, 2024 | |
| ENSG The Ensign Group | Maintains: Outperform | $165 → $168 | $172.45 | -2.58% | 8 | Oct 25, 2024 | |
| ADUS Addus HomeCare | Maintains: Outperform | $140 → $145 | $117.34 | +23.57% | 10 | Sep 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $32 → $40 | $13.98 | +186.12% | 3 | Aug 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $4.5 → $5 | $3.18 | +57.23% | 10 | Jul 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Perform | n/a | $8.11 | - | 2 | Mar 7, 2024 |
Chemed
Jul 31, 2025
Maintains: Outperform
Price Target: $650 → $580
Current: $462.23
Upside: +25.48%
UnitedHealth Group
Jul 30, 2025
Maintains: Outperform
Price Target: $400 → $325
Current: $344.08
Upside: -5.55%
Centene
Jul 28, 2025
Maintains: Outperform
Price Target: $51 → $43
Current: $34.86
Upside: +23.35%
Humana
May 1, 2025
Maintains: Outperform
Price Target: $300 → $310
Current: $254.95
Upside: +21.59%
The Cigna Group
Jan 31, 2025
Maintains: Outperform
Price Target: $400 → $375
Current: $286.17
Upside: +31.04%
Teladoc Health
Jan 24, 2025
Maintains: Outperform
Price Target: $14 → $12
Current: $8.16
Upside: +47.06%
The Pennant Group
Nov 8, 2024
Maintains: Outperform
Price Target: $34 → $37
Current: $25.40
Upside: +45.67%
HCA Healthcare
Oct 28, 2024
Maintains: Outperform
Price Target: $390 → $400
Current: $419.08
Upside: -4.55%
The Ensign Group
Oct 25, 2024
Maintains: Outperform
Price Target: $165 → $168
Current: $172.45
Upside: -2.58%
Addus HomeCare
Sep 23, 2024
Maintains: Outperform
Price Target: $140 → $145
Current: $117.34
Upside: +23.57%
Aug 13, 2024
Maintains: Outperform
Price Target: $32 → $40
Current: $13.98
Upside: +186.12%
Jul 25, 2024
Maintains: Outperform
Price Target: $4.5 → $5
Current: $3.18
Upside: +57.23%
Mar 7, 2024
Maintains: Perform
Price Target: n/a
Current: $8.11
Upside: -